Clinical studies recruiting near Peoria

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · CON-10019, Peoria, IL · Colorado Prevention Center · NCT06024746 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · Illinois CancerCare-Peoria · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · OSF Children's Hospital of Illinois · National Cancer Institute (NCI) · NCT05099003 A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer
Phase 3 · Illinois CancerCare PC · BioNTech SE · NCT07365995 Pounce™ Thrombectomy System Retrospective Registry
Phase N/A · OSF St. Francis Medical Center · SurModics, Inc. · NCT05868161 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · OSF Children's Hospital of Illinois · National Cancer Institute (NCI) · NCT06172296 Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Illinois CancerCare-Peoria · NRG Oncology · NCT05624996 Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated C
Phase 3 · Illinois CancerCare-Peoria · Alliance for Clinical Trials in Oncology · NCT07321652 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · OSF Children's Hospital of Illinois · National Cancer Institute (NCI) · NCT05691478 Testing an Enhanced Digital Delivery Model for Inherited Cancer Genetic Testing in Young Adults With Cancer
NA · Illinois CancerCare-Peoria · Alliance for Clinical Trials in Oncology · NCT07091617 Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS
Phase 3 · OSF Saint Francis Medical Center · Eli Lilly and Company · NCT06890598 A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangement
Phase 1/Phase 2 · Local Institution - 2142 · Turning Point Therapeutics, Inc. · NCT03093116 A Study to Learn How Avacincaptad Pegol (Izervay™) is Used in Clinical Practice in People Who Have Geographic Atrophy
Phase N/A · Illinois Eye Center · Astellas Pharma Global Development, Inc. · NCT06779773 Efficacy of Atenativ in Patients With Congenital Antithrombin Deficiency Undergoing Surgery or Delivery
Phase 3 · Bleeding and Clotting Disorders Institute · Octapharma · NCT04918173 A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Saint Jude Midwest Affiliate · Children's Oncology Group · NCT04322318 A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previ
Phase 3 · Illinois Cancer Care · Pfizer · NCT07144280 A Study of Intismeran Autogene (V940) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants Wit
Phase 3 · Illinois Cancer Care ( Site 7003) · Merck Sharp & Dohme LLC · NCT06077760 Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Phase 3 · OSF Saint Francis Medical Center · NRG Oncology · NCT05946213 Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · Arizona Center for Cancer Care-Peoria · NRG Oncology · NCT06532279 LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2
Phase 3 · Tenax Investigational Site · Tenax Therapeutics, Inc. · NCT07288398 A Safety and Efficacy Study of a One-time Intravitreal Injection of SAR446597 in Participants With Geographic Atrophy Se
Phase 1/Phase 2 · Associated Retina Consultants - Peoria- Site Number : 840001 · Sanofi · NCT07215234 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Illinois CancerCare-Peoria · NRG Oncology · NCT05174169 Comparing Impact of Treatment Before or After Surgery in Patients With Stage II-IIIB Resectable Non-small Cell Lung Canc
Phase 3 · Illinois CancerCare-Peoria · Alliance for Clinical Trials in Oncology · NCT06632327 Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Illinois CancerCare-Peoria · Alliance for Clinical Trials in Oncology · NCT06931340 Sickle Cell Clinical Research and Intervention Program
Phase N/A · Children's Hospital of Illinois at OSF-Saint Francis Medical · St. Jude Children's Research Hospital · NCT02098863 A Study of Vonicog Alfa (rVWF) in Children With Severe Von Willebrand Disease (vWD)
Phase 3 · Bleeding and Clotting Disorders Institute · Takeda · NCT05582993 A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS
Phase 3 · ILCC. Illinois Cancer Centers · Takeda · NCT06499285 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Illinois CancerCare-Peoria · Alliance for Clinical Trials in Oncology · NCT06876714 A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-
Phase 2 · Illinois Cancer Care ( Site 7005) · Merck Sharp & Dohme LLC · NCT06890884 Stereotactic Radiosurgery Compared With Hippocampal-Avoidant Whole Brain Radiotherapy (HA-WBRT) Plus Memantine for 5 or
Phase 3 · Methodist Medical Center of Illinois · Canadian Cancer Trials Group · NCT03550391

Look up another city

Look up another condition